Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - LONG-TERM DEBT
Long-term Debt URGN - UroGen Pharma Ltd.
99.4 M
LAST VALUE
1480.30%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR